Literature DB >> 19498422

Ric-3 chaperone-mediated stable cell-surface expression of the neuronal alpha7 nicotinic acetylcholine receptor in mammalian cells.

Ana Sofía Vallés1, Ana M Roccamo, Francisco J Barrantes.   

Abstract

AIM: Studies of the alpha7-type neuronal nicotinic acetylcholine receptor (AChR), one of the receptor forms involved in many physiologically relevant processes in the central nervous system, have been hampered by the inability of this homomeric protein to assemble in most heterologous expression systems. In a recent study, it was shown that the chaperone Ric-3 is necessary for the maturation and functional expression of alpha7-type AChRs(1). The current work aims at obtaining and characterizing a cell line with high functional expression of the human alpha7 AChR.
METHODS: Ric-3 cDNA was incorporated into SHE-P1-halpha7 cells expressing the alpha7-type AChR. Functional studies were undertaken using single-channel patch-clamp recordings. Equilibrium and kinetic [(125)I]alpha-bungarotoxin binding assays, as well as fluorescence microscopy using fluorescent alpha-bungarotoxin, anti-alpha7 antibody, and GFP-alpha7 were performed on the new clone.
RESULTS: The human alpha7-type AChR was stably expressed in a new cell line, which we coined SHE-P1-halpha7-Ric-3, by co-expression of the chaperone Ric-3. Cell-surface AChRs exhibited [(125)I]alphaBTX saturable binding with an apparent K(D) of about 55 nmol/L. Fluorescence microscopy revealed dispersed and micro-clustered AChR aggregates at the surface of SHE-P1-halpha7-Ric-3 cells. Larger micron-sized clusters were observed in the absence of receptor-clustering proteins or upon aggregation with anti-alpha7 antibodies. In contrast, chaperone-less SHE-P1-halpha7 cells expressed only intracellular alpha7 AChRs and failed to produce detectable single-channel currents.
CONCLUSION: The production of a stable and functional cell line of neuroepithelial lineage with robust cell-surface expression of neuronal alpha7-type AChR, as reported here, constitutes an important advance in the study of homomeric receptors in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19498422      PMCID: PMC4002380          DOI: 10.1038/aps.2009.54

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  38 in total

Review 1.  Nicotinic receptors in the brain: correlating physiology with function.

Authors:  S Jones; S Sudweeks; J L Yakel
Journal:  Trends Neurosci       Date:  1999-12       Impact factor: 13.837

Review 2.  Cys-loop receptors: new twists and turns.

Authors:  Henry A Lester; Mohammed I Dibas; David S Dahan; John F Leite; Dennis A Dougherty
Journal:  Trends Neurosci       Date:  2004-06       Impact factor: 13.837

3.  Metabolic cholesterol depletion hinders cell-surface trafficking of the nicotinic acetylcholine receptor.

Authors:  M F Pediconi; C E Gallegos; E B De Los Santos; F J Barrantes
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

4.  A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX.

Authors:  S Couturier; D Bertrand; J M Matter; M C Hernandez; S Bertrand; N Millar; S Valera; T Barkas; M Ballivet
Journal:  Neuron       Date:  1990-12       Impact factor: 17.173

5.  The interface between extracellular and transmembrane domains of homomeric Cys-loop receptors governs open-channel lifetime and rate of desensitization.

Authors:  Cecilia Bouzat; Mariana Bartos; Jeremías Corradi; Steven M Sine
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

6.  Properties of embryonic and adult muscle acetylcholine receptors transiently expressed in COS cells.

Authors:  Y Gu; A Franco; P D Gardner; J B Lansman; J R Forsayeth; Z W Hall
Journal:  Neuron       Date:  1990-08       Impact factor: 17.173

7.  Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line.

Authors:  Lingke Zhao; Yen-Ping Kuo; Andrew A George; Jian-Hong Peng; Madhuri Singh Purandare; Katherine M Schroeder; Ronald J Lukas; Jie Wu
Journal:  J Pharmacol Exp Ther       Date:  2003-03-06       Impact factor: 4.030

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  Coordinate morphological and biochemical interconversion of human neuroblastoma cells.

Authors:  R A Ross; B A Spengler; J L Biedler
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

10.  Muscarinic receptor subtypes in bovine adrenal medulla.

Authors:  K Yamanaka; S Kigoshi; I Muramatsu
Journal:  Biochem Pharmacol       Date:  1986-09-15       Impact factor: 5.858

View more
  7 in total

Review 1.  Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update.

Authors:  Arianna Crespi; Sara Francesca Colombo; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2017-04-19       Impact factor: 8.739

2.  Direct interaction of the resistance to inhibitors of cholinesterase type 3 protein with the serotonin receptor type 3A intracellular domain.

Authors:  Sita Nirupama Nishtala; Nelli Mnatsakanyan; Akash Pandhare; Chun Leung; Michaela Jansen
Journal:  J Neurochem       Date:  2016-03-11       Impact factor: 5.372

3.  Activation of α7 nicotinic receptors by orthosteric and allosteric agonists: influence on single-channel kinetics and conductance.

Authors:  Magda M Pałczyńska; Marie Jindrichova; Alasdair J Gibb; Neil S Millar
Journal:  Mol Pharmacol       Date:  2012-08-08       Impact factor: 4.436

4.  Xenopus laevis RIC-3 enhances the functional expression of the C. elegans homomeric nicotinic receptor, ACR-16, in Xenopus oocytes.

Authors:  Hayley M Bennett; Kristin Lees; Kate M Harper; Andrew K Jones; David B Sattelle; Susan Wonnacott; Adrian J Wolstenholme
Journal:  J Neurochem       Date:  2012-10-10       Impact factor: 5.372

5.  Chemical chaperones exceed the chaperone effects of RIC-3 in promoting assembly of functional α7 AChRs.

Authors:  Alexander Kuryatov; Jayanta Mukherjee; Jon Lindstrom
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

6.  Functional expression of human α9* nicotinic acetylcholine receptors in X. laevis oocytes is dependent on the α9 subunit 5' UTR.

Authors:  Olena Filchakova; J Michael McIntosh
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

7.  Resistance to Inhibitors of Cholinesterase 3 (Ric-3) Expression Promotes Selective Protein Associations with the Human α7-Nicotinic Acetylcholine Receptor Interactome.

Authors:  Matthew J Mulcahy; Sydney B Blattman; Francisco J Barrantes; Ronald J Lukas; Edward Hawrot
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.